Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | PAM | P19021 | 1/20 | 0.38 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.31 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.31 |
| ▸ | BLM | P54132 | 2/20 | 0.31 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20505819 | 1.00 | ALDH1A1 (0.58) | ALDH1A1CYP2D6ALOX15PAMGABRR1 | |
| SCHEMBL7136638 | 1.00 | ALDH1A1 (0.58) | ALDH1A1CYP2D6ALOX15PAMGABRR1 | |
| SCHEMBL20505388 | 0.83 | ALDH1A1 (0.41) | ALDH1A1CYP2D6ALOX15 | |
| Glutaconate SCHEMBL12230 | 0.77 | — | — | |
| Glutaconate SCHEMBL2514167 | 0.77 | ALDH1A1 (0.65) | ALDH1A1CYP2D6ALOX15PAMGABRR1 | |
| Glutaconate SCHEMBL688877 | 0.77 | — | — | |
| Glutaconate SCHEMBL21841 | 0.77 | — | — | |
| SCHEMBL213024 | 0.75 | CYP2D6 (1.00) | ALDH1A1CYP2D6ALOX15PAMGABRR1 | |
| SCHEMBL190067 | 0.75 | CYP2D6 (1.00) | ALDH1A1CYP2D6ALOX15PAMGABRR1 | |
| SCHEMBL3134391 | 0.75 | CYP2D6 (1.00) | ALDH1A1CYP2D6ALOX15PAMGABRR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260009056-A1 | PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES | ZYMOCHEM INC (US) | 2026-01-08 | — | — | US | disclosed |
| US-12258610-B2 | Production of chemicals from renewable sources | ZYMOCHEM, INC. (US) | 2025-03-25 | — | — | US | disclosed |
| US-12084704-B2 | Methods for producing isobutene from 3-methylcrotonic acid | GLOBAL BIOENERGIES (FR) | 2024-09-10 | — | — | US | disclosed |
| CN-110914441-B | Improved process for producing isobutene from 3-methylcrotonic acid | 环球生物能源公司 | 2024-06-28 | — | — | CN | disclosed |
| EP-3622080-B1 | IMPROVED METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2024-03-27 | — | — | EP | disclosed |
| US-11692208-B2 | Production of chemicals from renewable sources | ZYMOCHEM, INC. (US) | 2023-07-04 | — | — | US | disclosed |
| US-20230109883-A1 | PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES | ZYMOCHEM, INC. | 2023-04-13 | — | — | US | disclosed |
| US-20220372528-A1 | PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES | ZYMOCHEM, INC. | 2022-11-24 | — | — | US | disclosed |
| US-20210403956-A1 | METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2021-12-30 | — | — | US | disclosed |
| US-11124806-B2 | Methods for producing isobutene from 3-methylcrotonic acid | GLOBAL BIOENERGIES (FR) | 2021-09-21 | — | — | US | disclosed |
| EP-3599246-A1 | MEANS AND METHODS FOR SYNTHESIZING PRECURSORS OF Y-AMINOBUTYRIC ACID (GABA) ANALOGS | RIJKSUNIVERSITEIT GRONINGEN (NL) | 2020-01-29 | — | — | EP | disclosed |
| EP-3535281-A1 | FUSION POLYPEPTIDES | Oxford University Innovation Limited (GB) | 2019-09-11 | — | — | EP | disclosed |
| US-20190255167-A1 | FUSION POLYPEPTIDES | UNIV OXFORD INNOVATION LTD (GB) | 2019-08-22 | — | — | US | disclosed |
| US-20180371503-A1 | METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2018-12-27 | — | — | US | disclosed |
| EP-3377639-A2 | METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | Global Bioenergies (FR) | 2018-09-26 | — | — | EP | disclosed |
| WO-2003065979-A2 | METHODS OF DIAGNOSIS, MONITORING AND TREATMENT OF FERTILITY | NORTH SHORE-LONG ISLAND JEWISH RESEARCH INSTITUTE (US) | 2003-08-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260009056-A1 | PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES | HPD, PGD, ADSL | ALDH1A1 200/4885CYP2D6 485/4885ALOX15 353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.